Clinical symptoms of the effectiveness of combination therapy for onychomycosis of dermatomycete etiology

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Onychomycosis is widespread all over the world. The choice of treatment tactics continues to be a difficult task for dermatologists. The use of combination therapy showed high clinical and mycological results of treatment, and also reduced the risk of relapses after discontinuation of therapy. Evaluation of the effectiveness of this therapy is based on knowledge of the reverse development of clinical symptoms.

Full Text

Restricted Access

About the authors

Alexey B. Yakovlev

Central State Medical Academy of the Administrative Department of the President of Russian Federation

Author for correspondence.
Email: aby@rinet.ru
ORCID iD: 0000-0001-7073-9511

MD, PhD, Docent

Russian Federation, Moscow

O. A. Golanova

Central State Medical Academy of the Administrative Department of the President of Russian Federation

Email: aby@rinet.ru
Russian Federation, Moscow

References

  1. Kaur R, Kashyap B, Bhalla P. Onychomycosis – epidemiology, diagnosis and management. Indian J Med Microbiol. 2008;26(2):108-16. doi: 10.4103/0255-0857.40522.
  2. Bodman MA, Krishnamurthy K. Onychomycosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. 2020 Aug 8. PMID: 28722883.
  3. Kasikhina EI, Yakovlev AB. Onychomycosis. Attending Physician. Russian Journal. 2012;(5):49-53. (in Russian)
  4. Saliy ЕА. Onychomycosis. Epidemiology, etiopathogenesis, treatment Dermatovenerology. Cosmetology. Sexual Pathology. Ukrainian Journal. 2011;(1-4):110-4. (in Russian)
  5. Sergeev AYu. Update views on pathogenesis of onychomycosis. International Journal of Immunopathology, Allergology, Infectology. Russian Journal. 2000;(1):100-9. (in Russian)
  6. Sergeev YuV, Mokina EV, Sergeev AYu, Burtseva GN, Baranova MO, Savchenko NV, Sergeev VYu. Local and combined therapy of onychomycosis. Moscow: National Academy of Mycology; 2015. (in Russian)
  7. Rashid A, Scott E, Richardson MD. Early events in the invasion of the human nail plate by Trichophyton mentagrophytes. Br J Dermatol. 1995;133(6):932-40.
  8. Gerasimchuk EV. the role of Modern topical treatment to skin and nail fungal infections in older adults. Clinical gerontology. Russian Journal. 2016;(7-8):63-5. (in Russian)
  9. Potekaev NN, Molochkov VA, Shakhova LM, Shishkova MV. Combined therapy of onychomycosis: approaches and prospects. Advances in Medical Mycology. Russian Journal. 2004;(4):307-8. (in Russian)
  10. Ryder NS. Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol. 1992;126(Suppl.39):2-7.
  11. Sigurgeirsson B, Olafsson JH, Steinsson JB, Pau C, Billstein S, Evans GV. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol. 2002;138(3):353-7.
  12. Baran R, Hay RJ, Garduno JI. Review of antifungal therapy and the severity index for assessing onychomycosis: part I. J Dermatolog Treat. 2008;19(2):72-81.
  13. Grover C, Khurana A. An update on treatment of onychomycosis. Mycoses. 2012;55(6):541-51. doi: 10.1111/j.1439-0507.2012.02199.x.
  14. Bhatta AK, Keyal U, Wang X, Gellen E. A review of the mechanism of action of lasers and photodynamic therapy for onychomycosis. Lasers Med Sci. 2017;32(2):469-74.
  15. Potekaev NN, Kruglova LS. Lasers in Dermatology and Cosmetology. Moscow: Alkor Publishers; 2018. (in Russian)
  16. Kawa N, Lee KC, Anderson RR, Garibyan L. Onychomycosis: A review of new and emerging topical and device-based treatments. J Clin Aesthet Dermatol. 2019;12(10):29-34.
  17. Sergeev YuV, Sergeev VYu. What is a combination theatment and how it may be used in onychomycosis. Herald of Venerology and Dermatology. Russian Journal. 2011;(5):125-30. (in Russian)
  18. Lecha M, Alsina M, Torres Rodriguez JM, de Erenchun FR, Mirada A, Rossi AB. An open-label, multicenter study of the combination of amorolfine nail lacquer and oral itraconazole compared with oral itraconazole alone in the treatment of severe toenail onychomycosis. Curr Ther Res. 2002;63(6):366-79.
  19. Leelavathi M, Noorlaily MN. Onychomycosis nailed. Malays Fam Physician. 2014;9(1):2-7.
  20. Rukavishnikova VM. Mycosis of the feet. Moscow: AlexCom; 2003. (in Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Distal normotrophic type of nail lesion: onychorexis is visible. Local therapy with amorolfine varnish started.

Download (228KB)
3. Fig. 2. Normotrophic distal-lateral type of nail damage to the 1st toe of the right foot and the combined white superficial and hypertrophic type of nail damage to the 3rd, 4th, 5th toes.

Download (111KB)
4. Fig. 3. Hypertrophic total type of nail lesion, "tower nails".

Download (219KB)
5. Fig. 4. Successful treatment of onychomycosis. A demarcation zone in the form of a rainbow stripe and residual subungual hyperkeratosis are visible.

Download (226KB)
6. Fig. 5. The beginning of the formation of the demarcation zone in normotrophic distal onychomycosis.

Download (165KB)

Copyright (c) 2020 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 86501 от 11.12.2023 г
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80653 от 15.03.2021 г
.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies